Does RISANKIZUMAB-RZAA Cause Myalgia? 315 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 315 reports of Myalgia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
315
Reports of Myalgia with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
1
Deaths
66
Hospitalizations
How Dangerous Is Myalgia From RISANKIZUMAB-RZAA?
Of the 315 reports, 1 (0.3%) resulted in death, 66 (21.0%) required hospitalization.
Is Myalgia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 315 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Myalgia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA